Literature DB >> 10493936

Aberrant expression of cAMP-response-element-binding protein ('CREB') induces apoptosis.

K Saeki1, A Yuo, E Suzuki, Y Yazaki, F Takaku.   

Abstract

We have reported previously that cAMP-response-element-binding protein (CREB) was phosphorylated in a cell-cycle-dependent manner, showing that it was phosphorylated at early S-phase at casein kinase II target sites. To assess the possible involvement of CREB in cell cycle progression, CREB expression vector was transiently transfected into various cells. Unexpectedly we found that transfection with CREB expression vector resulted in an abundance of dead cells. Morphological examination revealed that these cells had undergone apoptosis. The coincidence of CREB overexpression and apoptosis induction at the individual cell level was confirmed by a immunohistochemical study. To confirm that overexpression of CREB was the cause of apoptosis, a dominant-negative mutant of CREB, KCREB, was co-expressed with the wild type. The co-existence of KCREB effectively rescued CREB-mediated apoptosis in a dose-dependent manner, verifying that apoptosis was truly a specific effect of overexpressed CREB and not an artifact of the transfection procedure. Deletion analysis indicates that neither the Q1 transactivation domain, which functions in transcription, nor the kinase-inducible domain, in which a cluster of various kinase targets exists, is necessary; however, the Q2 transactivation domain is required for the induction of apoptosis. A more precise study indicates that the four-residue stretch Glu-Glu-Ala-Ala at the most C-terminal region of the Q2 domain is especially important for the induction of apoptosis. Thus overexpressed CREB induces apoptosis by transmitting certain signals from the C-terminal portion of the Q2 domain. Possible roles of cell-cycle-regulated phosphorylation and also an elevation of the intracellular cAMP level in CREB-induced apoptosis are suggested.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493936      PMCID: PMC1220548     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Br-cAMP induction of apoptosis in synchronized CHO cells.

Authors:  L R Gurley; A L Jandacek; J G Valdez; R J Sebring; J A D'Anna; T T Puck
Journal:  Somat Cell Mol Genet       Date:  1998-05

2.  CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases.

Authors:  M Sheng; M A Thompson; M E Greenberg
Journal:  Science       Date:  1991-06-07       Impact factor: 47.728

3.  Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133.

Authors:  G A Gonzalez; M R Montminy
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

4.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

5.  CREB and its associated proteins act as survival factors for human melanoma cells.

Authors:  D Jean; M Harbison; D J McConkey; Z Ronai; M Bar-Eli
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

6.  A dominant repressor of cyclic adenosine 3',5'-monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo.

Authors:  K M Walton; R P Rehfuss; J C Chrivia; J E Lochner; R H Goodman
Journal:  Mol Endocrinol       Date:  1992-04

7.  Evidence that glucocorticoid- and cyclic AMP-induced apoptotic pathways in lymphocytes share distal events.

Authors:  D R Dowd; R L Miesfeld
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

8.  An extended alpha-helix and specific amino acid residues opposite the DNA-binding surface of the cAMP response element binding protein basic domain are important for human T cell lymphotropic retrovirus type I Tax binding.

Authors:  Y Tang; F Tie; I Boros; R Harrod; M Glover; C Z Giam
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

9.  A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence.

Authors:  G A Gonzalez; K K Yamamoto; W H Fischer; D Karr; P Menzel; W Biggs; W W Vale; M R Montminy
Journal:  Nature       Date:  1989-02-23       Impact factor: 49.962

10.  Identification of a cyclic-AMP-responsive element within the rat somatostatin gene.

Authors:  M R Montminy; K A Sevarino; J A Wagner; G Mandel; R H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

View more
  10 in total

Review 1.  Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.

Authors:  Z Z Chong; F Li; K Maiese
Journal:  Histol Histopathol       Date:  2005-01       Impact factor: 2.303

2.  Progesterone inhibition of voltage-gated calcium channels is a potential neuroprotective mechanism against excitotoxicity.

Authors:  Jessie I Luoma; Brooke G Kelley; Paul G Mermelstein
Journal:  Steroids       Date:  2011-03-01       Impact factor: 2.668

3.  Paradoxical effects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax expressing cells.

Authors:  Cynthia de la Fuente; Lai Wang; Dai Wang; Longwen Deng; Kaili Wu; Hong Li; L Dana Stein; Thomas Denny; Frederick Coffman; Kylene Kehn; Shanese Baylor; Anil Maddukuri; Anne Pumfery; Fatah Kashanchi
Journal:  Mol Cell Biochem       Date:  2003-03       Impact factor: 3.396

4.  A Role for cAMP and Protein Kinase A in Experimental Necrotizing Enterocolitis.

Authors:  Brian P Blackwood; Douglas R Wood; Carrie Yuan; Joseph Nicolas; Isabelle G De Plaen; Kathryn N Farrow; Pauline Chou; Jerrold R Turner; Catherine J Hunter
Journal:  Am J Pathol       Date:  2016-12-08       Impact factor: 4.307

5.  Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract.

Authors:  Addanki P Kumar; Shylesh Bhaskaran; Manonmani Ganapathy; Katherine Crosby; Michael D Davis; Peter Kochunov; John Schoolfield; I-Tien Yeh; Dean A Troyer; Rita Ghosh
Journal:  Clin Cancer Res       Date:  2007-05-01       Impact factor: 12.531

6.  Computational identification of transcriptional regulators in human endotoxemia.

Authors:  Tung T Nguyen; Panagiota T Foteinou; Steven E Calvano; Stephen F Lowry; Ioannis P Androulakis
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

7.  The expression and role of serotonin receptor 5HTR2A in canine osteoblasts and an osteosarcoma cell line.

Authors:  Shay Bracha; Austin Viall; Cheri Goodall; Bernadette Stang; Craig Ruaux; Bernard Seguin; Patrick E Chappell
Journal:  BMC Vet Res       Date:  2013-12-12       Impact factor: 2.741

8.  Temporal profiles of synaptic plasticity-related signals in adult mouse hippocampus with methotrexate treatment.

Authors:  Miyoung Yang; Juhwan Kim; Sung-Ho Kim; Joong-Sun Kim; Taekyun Shin; Changjong Moon
Journal:  Neural Regen Res       Date:  2012-07-25       Impact factor: 5.135

Review 9.  Regulation of Cancer Cell Responsiveness to Ionizing Radiation Treatment by Cyclic AMP Response Element Binding Nuclear Transcription Factor.

Authors:  Francesca D'Auria; Lucia Centurione; Maria Antonietta Centurione; Antonio Angelini; Roberta Di Pietro
Journal:  Front Oncol       Date:  2017-05-05       Impact factor: 6.244

10.  RCAN1 is an important mediator of glucocorticoid-induced apoptosis in human leukemic cells.

Authors:  Kazuaki Nagao; Yujiro Iwai; Toshiyuki Miyashita
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.